Ohba SI - Search Results

1

Inhibition of kynurenine production by N,O-substituted hydroxylamine derivatives.

Iijima M, Otsuka Y, Ohba SI, Momose I. Iijima M, et al. Among authors: ohba si. Bioorg Med Chem Lett. 2024 Jul 1;106:129731. doi: 10.1016/j.bmcl.2024.129731. Epub 2024 Apr 14. Bioorg Med Chem Lett. 2024. PMID: 38621594

2

Human pancreatic cancer cells under nutrient deprivation are vulnerable to redox system inhibition.

Onodera T, Momose I, Adachi H, Yamazaki Y, Sawa R, Ohba SI, Kawada M. Onodera T, et al. Among authors: ohba si. J Biol Chem. 2020 Dec 4;295(49):16678-16690. doi: 10.1074/jbc.RA120.013893. Epub 2020 Sep 25. J Biol Chem. 2020. PMID: 32978257 Free PMC article.

3

In vivo imaging of proteasome inhibition using a proteasome-sensitive fluorescent reporter.

Momose I, Tatsuda D, Ohba S, Masuda T, Ikeda D, Nomoto A. Momose I, et al. Cancer Sci. 2012 Sep;103(9):1730-6. doi: 10.1111/j.1349-7006.2012.02352.x. Epub 2012 Jul 11. Cancer Sci. 2012. PMID: 22676179 Free PMC article.

4

Antitumor effects of tyropeptin-boronic acid derivatives: New proteasome inhibitors.

Momose I, Abe H, Watanabe T, Ohba S, Yamazaki K, Dan S, Yamori T, Masuda T, Nomoto A. Momose I, et al. Cancer Sci. 2014 Dec;105(12):1609-15. doi: 10.1111/cas.12542. Epub 2014 Oct 21. Cancer Sci. 2014. PMID: 25251038 Free PMC article.

5

Mitochondrial inhibitors show preferential cytotoxicity to human pancreatic cancer PANC-1 cells under glucose-deprived conditions.

Momose I, Ohba S, Tatsuda D, Kawada M, Masuda T, Tsujiuchi G, Yamori T, Esumi H, Ikeda D. Momose I, et al. Biochem Biophys Res Commun. 2010 Feb 12;392(3):460-6. doi: 10.1016/j.bbrc.2010.01.050. Epub 2010 Jan 18. Biochem Biophys Res Commun. 2010. PMID: 20083087

6

Androprostamine A: a unique antiprostate cancer agent.

Yamazaki Y, Abe H, Sakashita C, Ohba SI, Watanabe T, Momose I, Kawada M. Yamazaki Y, et al. Among authors: ohba si. J Antibiot (Tokyo). 2021 Oct;74(10):717-725. doi: 10.1038/s41429-021-00449-8. Epub 2021 Jul 28. J Antibiot (Tokyo). 2021. PMID: 34321608

7

Author Correction: Androprostamine A: a unique antiprostate cancer agent.

Yamazaki Y, Abe H, Sakashita C, Ohba SI, Watanabe T, Momose I, Kawada M. Yamazaki Y, et al. Among authors: ohba si. J Antibiot (Tokyo). 2021 Oct;74(10):767. doi: 10.1038/s41429-021-00467-6. J Antibiot (Tokyo). 2021. PMID: 34408289 No abstract available.

8

Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells.

Kawada M, Inoue H, Ohba S, Masuda T, Momose I, Ikeda D. Kawada M, et al. Int J Cancer. 2010 Feb 15;126(4):810-8. doi: 10.1002/ijc.24915. Int J Cancer. 2010. PMID: 19795463 Free article.

9

Augmentation of cellular immunity by kigamicin D.

Masuda T, Ohba S, Kawada M, Iijima M, Inoue H, Osono M, Ikeda D, Kunimoto S. Masuda T, et al. J Antibiot (Tokyo). 2006 Apr;59(4):215-9. doi: 10.1038/ja.2006.30. J Antibiot (Tokyo). 2006. PMID: 16830888

10

Metacytofilin Is a Potent Therapeutic Drug Candidate for Toxoplasmosis.

Leesombun A, Iijima M, Umeda K, Kondoh D, Pagmadulam B, Abdou AM, Suzuki Y, Ohba SI, Isshiki K, Kimura T, Kubota Y, Sawa R, Nihei CI, Nishikawa Y. Leesombun A, et al. Among authors: ohba si. J Infect Dis. 2020 Feb 18;221(5):766-774. doi: 10.1093/infdis/jiz501. J Infect Dis. 2020. PMID: 31573038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page